User:Mr. Ibrahem/Relugolix

Relugolix, sold under the brand names Orgovyx and Relumina, is a medication used to treat prostate cancer and uterine fibroids. In prostate cancer it is used for cases that are advanced but hormone sensitive. It is taken by mouth once per day.

Common side effects include hot flashes, increase blood sugar, muscle pain, low hemoglobin, tiredness, and constipation. Other side effects may include QT prolongation. Use in pregnancy, by either partner, may harm the baby. It is a gonadotropin-releasing hormone (GnRH) receptor antagonist, which blocks the production of testosterone.

Relugolix was approved for medical use in Japan in 2019, the United States in 2020, and Europe in 2022. In the United States a month of treatment costs about 2,450 USD per month as of 2022. It is being studied in endometriosis. It is also one component of relugolix/estradiol/norethisterone.